{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:08:38Z","timestamp":1770980918755,"version":"3.50.1"},"publisher-location":"Berlin, Heidelberg","reference-count":45,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540692966","type":"print"},{"value":"9783540692973","type":"electronic"}],"license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-3-540-69297-3_15","type":"book-chapter","created":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T04:46:44Z","timestamp":1227761204000},"page":"161-169","source":"Crossref","is-referenced-by-count":80,"title":["Chemoprevention of Oesophageal Cancer and the AspECT Trial"],"prefix":"10.1007","author":[{"given":"Debasish","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Chilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz A.","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"15_CR1_15","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/carcin\/bgi114","volume":"26","author":"SI Abdalla","year":"2005","unstructured":"Abdalla SI, Sanderson IR, Fitzgerald RC (2005) Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells. Carcinogenesis 26:1627\u20131633","journal-title":"Carcinogenesis"},{"key":"15_CR2_15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0016-5107(99)70339-1","volume":"50","author":"M Alikhan","year":"1999","unstructured":"Alikhan M, Rex D, Khan A, Rahmani E, Cummings O, Ulbright TM (1999) Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointest Endosc 50:23\u201326","journal-title":"Gastrointest Endosc"},{"key":"15_CR3_15","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1111\/j.1572-0241.2002.05902.x","volume":"97","author":"B Avidan","year":"2002","unstructured":"Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ (2002) Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 97:1930\u20131936","journal-title":"Am J Gastroenterol"},{"key":"15_CR4_15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00042737-200012060-00013","volume":"12","author":"K Bani-Hani","year":"2000","unstructured":"Bani-Hani K, Sue-Ling H, Johnston D, Axon AT, Martin IG (2000) Barrett's oesophagus: results from a 13-year surveillance programme. Eur J Gastroenterol Hepatol 12:649\u2013654","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"15_CR5_15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1055\/s-2007-966653","volume":"39","author":"J Boyer","year":"2007","unstructured":"Boyer J, Laugier R, Chemali M, Arpurt J P, Bousti\u00e8re C, Canard JM, Dalbies PA, Gay G, Escourrou J, Napol\u00e9on B, Palazzo L, Ponchon T, Richard-Mollard B, Sautereau D, Tucat G, Vedrenne B; French Society of Digestive Endoscopy SFED (2007) French Society of Digestive Endoscopy SFED guideline: monitoring of patients with Barrett's esophagus. Endoscopy 39:840\u2013842","journal-title":"Endoscopy"},{"key":"15_CR6_15","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1053\/gast.2001.25111","volume":"120","author":"NS Buttar","year":"2001","unstructured":"Buttar NS, Wang KK, Sebo TJ, Riehle DM, Krishnadath KK, Lutzke LS, Anderson MA, Petterson TM, Burgart LJ (2001) Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 120:1630\u20131639","journal-title":"Gastroenterology"},{"key":"15_CR7_15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM198510033131404","volume":"313","author":"AJ Cameron","year":"1985","unstructured":"Cameron AJ, Ott BJ, Payne WS (1985) The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313:857\u2013859","journal-title":"N Engl J Med"},{"key":"15_CR8_15","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1111\/j.1572-0241.2003.07666.x","volume":"98","author":"M Conio","year":"2003","unstructured":"Conio M, Blanchi S, Lapertosa G, Ferraris R, Sablich R, Marchi S, D'Onofrio V, Lacchin T, Iaquinto G, Missale G, Ravelli P, Cestari R, Benedetti G, Macr\u00ec G, Fiocca R, Munizzi F, Filiberti R (2003) Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol 98:1931\u20131939","journal-title":"Am J Gastroenterol"},{"key":"15_CR9_15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/gast.2002.31879","volume":"122","author":"DA Corley","year":"2002","unstructured":"Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA (2002) Surveillance and survival in Barrett'sadenocarcinomas: a population-based study. Gastroenterology 122:633\u2013640","journal-title":"Gastroenterology"},{"key":"15_CR10_15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/gast.2003.50008","volume":"124","author":"DA Corley","year":"2003","unstructured":"Corley DA, Kerlikowske K, Verma R, Buffler P (2003) Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124:47\u201356","journal-title":"Gastroenterology"},{"key":"15_CR11_15","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1572-0241.2008.01790.x","volume":"103","author":"D Das","year":"2008","unstructured":"Das D, Ishaq S, Harrison R, Kosuri K, Harper E, Decaestecker J, Sampliner R, Attwood S, Barr H, Watson P, Moayyedi P, Jankowski J (2008) Management of Barrett's esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial. Am J Gastroenterol 103:1079\u20131089","journal-title":"Am J Gastroenterol"},{"key":"15_CR12_15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/gast.2002.30297","volume":"122","author":"GS Dulai","year":"2002","unstructured":"Dulai GS, Guha S, Kahn KL, Gornbein J, Weinstein WM (2002) Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 122:26\u201333","journal-title":"Gastroenterology"},{"key":"15_CR13_15","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","volume":"99","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB, Aguirre T V, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE (2004) Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol 99:1877\u20131883","journal-title":"Am J Gastroenterol"},{"key":"15_CR14_15","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/j.1572-0241.2003.07454.x","volume":"98","author":"MA Eloubeidi","year":"2003","unstructured":"Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB (2003) Temporal trends (1973\u20131997) in survival of patients with esophageal adenocarci-noma in the United States: a glimmer of hope?. Am J Gastroenterol 98:1627\u20131633","journal-title":"Am J Gastroenterol"},{"key":"15_CR15_15","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1172\/JCI119018","volume":"98","author":"RC Fitzgerald","year":"1996","unstructured":"Fitzgerald RC, Omary MB, Triadafilopoulos G (1996) Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model. J Clin Invest 98:2120\u20132128","journal-title":"J Clin Invest"},{"key":"15_CR16_15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/jnci\/djk112","volume":"99","author":"EI Heath","year":"2007","unstructured":"Heath EI, Canto MI, Piantadosi S, Montgomery E, Weinstein WM, Herman JG, Dannenberg AJ, Yang V W, Shar AO, Hawk E, Forastiere AA (2007) Chemoprevention for Barrett's Esophagus Trial Research Group. Secondary chemopreven-tion of Barrett's esophagus with celecoxib: results of a randomized trial. J Natl Cancer Inst 99:545\u2013557","journal-title":"J Natl Cancer Inst"},{"key":"15_CR17_15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5694\/j.1326-5377.2004.tb05991.x","volume":"180","author":"LC Hillman","year":"2004","unstructured":"Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC (2004) Proton pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med J Aust 180:387\u2013391","journal-title":"Med J Aust"},{"key":"15_CR18_15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2036.2007.03579.x","volume":"27","author":"LC Hillman","year":"2008","unstructured":"Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC (2008) Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus. Aliment Pharmacol Ther 27:321\u2013336","journal-title":"Aliment Pharmacol Ther"},{"key":"15_CR19_15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-138-3-200302040-00009","volume":"138","author":"JM Inadomi","year":"2003","unstructured":"Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N (2003) Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 138:176\u2013186","journal-title":"Ann Intern Med"},{"key":"15_CR20_15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0002-9440(10)65346-1","volume":"154","author":"JA Jankowski","year":"1999","unstructured":"Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, Kerr D, Young LS (1999) Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 154:965\u2013973","journal-title":"Am J Pathol"},{"key":"15_CR21_15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/gast.2002.31599","volume":"122","author":"JA Jankowski","year":"2002","unstructured":"Jankowski JA, Provenzale D, Moayyedi P (2002) Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the West (systematic review). Gastroenterology 122:588\u2013590","journal-title":"Gastroenterology"},{"key":"15_CR22_15","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/70995","volume":"5","author":"MK Jones","year":"1999","unstructured":"Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS (1999) Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 5:1418\u20131423","journal-title":"Nat Med"},{"key":"15_CR23_15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","volume":"118","author":"EC Klinkenberg-Knol","year":"2000","unstructured":"Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, Prichard P, Lloyd D, Havu N, Frame MH, Rom\u00e0n J, Walan A; Long-Term Study Group (2000) Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 118:661\u2013669","journal-title":"Gastroenterology"},{"key":"15_CR24_15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren J, Bergstrom R, Lindgren A, Nyr\u00e9n O (1999) Symptomatic gastro-esophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825\u2013831","journal-title":"N Engl J Med"},{"key":"15_CR25_15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2036.2007.03582.x","volume":"27","author":"P Moayyedi","year":"2008","unstructured":"Moayyedi P, Burch N, Akhtar-Danesh N, Enaganti SK, Harrison R, Talley NJ, Jankowski J (2008) Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther 27:316\u2013320","journal-title":"Aliment Pharmacol Ther"},{"key":"15_CR26_15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/hupa.2001.23511","volume":"32","author":"E Montgomery","year":"2001","unstructured":"Montgomery E, Goldblum JR, Greenson JK, Haber MM, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Zahurak ML, Hart J (2001) Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 32:379\u2013388","journal-title":"Hum Pathol"},{"key":"15_CR27_15","first-page":"990","volume":"96","author":"CD Morris","year":"2001","unstructured":"Morris CD, Armstrong GR, Bigley G, Green H, Attwood SE (2001) Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarci-noma sequence. Am J Gastroenterol 96:990\u2013996","journal-title":"Am J Gastroenterol"},{"key":"15_CR28_15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/gast.1999.0029900327","volume":"117","author":"R Ouatu-Lascar","year":"1999","unstructured":"Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G (1999) Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology 117:327\u2013335","journal-title":"Gastroenterology"},{"key":"15_CR29_15","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1080\/003655200453557","volume":"35","author":"FT Peters","year":"2000","unstructured":"Peters FT, Ganesh S, Kuipers EJ, Sluiter WJ, Karrenbeld A, de Jager-Krikken A, Klinkenberg-Knol EC, Lamers CB, Kleibeuker JH (2000) Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus. Scand J Gastroenterol 35:1238\u20131244","journal-title":"Scand J Gastroenterol"},{"key":"15_CR30_15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-5223(94)70178-4","volume":"108","author":"JH Peters","year":"1994","unstructured":"Peters JH, Clark G W, Ireland A P, Chandrasoma P, Smyrk TC, DeMeester TR (1994) Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 108:813\u2013821","journal-title":"J Thorac Cardiovasc Surg"},{"key":"15_CR31_15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","volume":"97","author":"H Pohl","year":"2005","unstructured":"Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinomas incidence. J Natl Cancer Inst 97:142\u2013146","journal-title":"J Natl Cancer Inst"},{"key":"15_CR32_15","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1111\/j.1572-0241.1999.01276.x","volume":"94","author":"D Provenzale","year":"1999","unstructured":"Provenzale D, Schmitt C, Wong JB (1999) Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 94:2043\u20132053","journal-title":"Am J Gastroenterol"},{"key":"15_CR33_15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1080\/00365520510015737","volume":"40","author":"K Ragunath","year":"2005","unstructured":"Ragunath K, Krasner N, Raman VS, Haqqani MT, Phillips CJ, Cheung I (2005) Endoscopic abla tion of dysplastic Barrett's oesophagus compar ing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand J Gastroenterol 40:750\u2013758","journal-title":"Scand J Gastroenterol"},{"key":"15_CR34_15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1053\/gast.2000.9302","volume":"119","author":"NJ Shaheen","year":"2000","unstructured":"Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS (2000) Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 119:333\u2013338","journal-title":"Gastroenterology"},{"key":"15_CR35_15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cgh.2006.03.001","volume":"4","author":"P Sharma","year":"2006","unstructured":"Sharma P, Falk G W, Weston A P, Reker D, Johnston M, Sampliner RE (2006) Dysplasia and cancer in a large multicentre cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 4:566\u2013572","journal-title":"Clin Gastroenterol Hepatol"},{"key":"15_CR36_15","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1111\/j.1572-0241.2005.00340.x","volume":"100","author":"M Solaymani-Dodaran","year":"2005","unstructured":"Solaymani-Dodaran M, Logan R F, West J, Card T (2005) Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses\u2014a population-based cohort study. Am J Gastroenterol 100:2616\u20132621","journal-title":"Am J Gastroenterol"},{"key":"15_CR37_15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1053\/gast.2002.30993","volume":"122","author":"RF Souza","year":"2002","unstructured":"Souza RF, Shewmake K, Terada LS, Spechler SJ (2002) Acid exposure activates the mitogen-acti-vated protein kinase pathways in Barrett's esophagus. Gastroenterology 122:299\u2013307","journal-title":"Gastroenterology"},{"key":"15_CR38_15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0016-5085(84)90090-8","volume":"87","author":"SJ Spechler","year":"1984","unstructured":"Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, Colton T, Schimmel EM (1984) Adenocarcinoma and Barrett's esophagus. An overrated risk?. Gastroenterology 87: 927\u2013933","journal-title":"Gastroenterology"},{"key":"15_CR39_15","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.1365-2036.2007.03528.x","volume":"26","author":"T Thomas","year":"2007","unstructured":"Thomas T, Abrams KR, de Caestecker JS, Robinson RJ (2007) Meta analysis:cancer risk in Barrett's oesophagus. Aliment Pharmacol Ther 26:1465\u20131477","journal-title":"Aliment Pharmacol Ther"},{"key":"15_CR40_15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","volume":"83","author":"M Tsujii","year":"1995","unstructured":"Tsujii M, DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overex-pressing prostaglandin endoperoxide synthase 2. Cell 83:493\u2013501","journal-title":"Cell"},{"key":"15_CR41_15","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1073\/pnas.94.7.3336","volume":"94","author":"M Tsujii","year":"1997","unstructured":"Tsujii M, Kawano S, DuBois RN (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94:3336\u20133340","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR42_15","doi-asserted-by":"publisher","first-page":"7987","DOI":"10.1038\/sj.onc.1204947","volume":"20","author":"M Umansky","year":"2001","unstructured":"Umansky M, Yasui W, Hallak A, Brill S, Shapira I, Halpern Z, Hibshoosh H, Rattan J, Meltzer S, Tahara E, Arber N (2001) Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus. Oncogene 20:7987\u20137991","journal-title":"Oncogene"},{"key":"15_CR43_15","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1053\/gast.1996.v111.pm8898632","volume":"111","author":"MF Vaezi","year":"1996","unstructured":"Vaezi MF, Richter JE (1996) Role of acid and duodenogastroesophageal reflux in gastroeso-phageal reflux disease. Gastroenterology 111:1192\u20131199","journal-title":"Gastroenterology"},{"key":"15_CR44_15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","volume":"6","author":"TL Vaughan","year":"2005","unstructured":"Vaughan TL, Dong LM, Blount PL, Ayub K, Odze RD, Sanchez CA, Rabinovitch PS, Reid BJ (2005) Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus:a prospective study. Lancet Oncol 6:945\u2013952","journal-title":"Lancet Oncol"},{"key":"15_CR45_15","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1572-0241.2008.01835.x","volume":"103","author":"KK Wang","year":"2008","unstructured":"Wang KK, Sampliner RE (2008) Updated Guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 103:788\u2013797","journal-title":"Am J Gastroenterol"}],"container-title":["Recent Results in Cancer Research","Cancer Prevention II"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-69297-3_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T09:59:54Z","timestamp":1632391194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-69297-3_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9783540692966","9783540692973"],"references-count":45,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-69297-3_15","relation":{},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}